MedTrace Logo

Preliminary Evaluation of CASTLE Barrier Prototype UK

NCT01530087 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2016-03-22

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to provide preliminary assessment of the safety and performance of a novel barrier formulation (CASTLE) in a small population of subjects with irritated peristomal skin.

Conditions

  • Peristomal Skin Complication

Interventions

DEVICE

CASTLE barrier

Prototype barrier to be used in place of current two piece device

Sponsors & Collaborators

  • Hollister Incorporated

    lead INDUSTRY

Principal Investigators

  • Richard Murahata, PhD · Hollister Incorporated

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2012-02-29
Completion
2012-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01530087 on ClinicalTrials.gov